对于患有复发性或耐火性固体瘤的儿童,阿特佐利祖马布与化疗相结合的可行性

Matthew E Campbell1, Sonja Stutzman1, Sharon Primeaux1

  • 1Division of Hematology/Oncology, Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas, USA.

Pediatric blood & cancer
|September 12, 2025
PubMed
概括

维塔斯试验发现,将阿特佐利祖马布 (免疫检查点抑制剂) 与化疗相结合是可行的,并且在患有复发或耐药固体瘤的儿童中耐受好. 这种组合治疗显示出有希望的结果,没有观察到剂量限制性毒性.

相关概念视频

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K